Exploiting Biomarkers for Targeted Therapies in Acute Myeloid Leukemia

1,712
Total downloads
7,575
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 01 Aug 2025

L1, a 3,3′-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells

Yi Kuang
Yong Jian
Dinghuan Wang
Lihao Bai
Kunlin Yu
Chunlin Wang
Wuling Liu
Sheng Liu
Wan Li
1 more
Xiao Xiao

doi 10.3389/fphar.2025.1564199

348 views

REVIEW

Published on 14 May 2025

Drug-tolerant persister cells in acute myeloid leukemia: pressing challenge and promising new strategies for treatment

Meng Li
Xiaoli Wang
Wenjuan He
Hao Zhou

doi 10.3389/fmed.2025.1586552

1,413 views

ORIGINAL RESEARCH

Published on 21 Mar 2025

Identifying acute myeloid leukemia subtypes based on pathway enrichment

Ling Zhong
Jiangti Luo
Junze Dong
Xiang Yang
Xiaosheng Wang

doi 10.3389/fphar.2025.1557112

1,216 views

ORIGINAL RESEARCH

Published on 28 Feb 2024

A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia

Xin Liu
Li Wang
Qian Kang
Cheng Feng
Jishi Wang

doi 10.3389/fphar.2024.1339465

2,410 views
2 citations

Share on

Frontiers in Medicine

Frontiers in Medicine

Gene and Cell Therapy

Participating Journals

Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- 3.3 impact factor
- 6.9 citescore
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- 4.8 impact factor
- 8.9 citescore

Impact

7,575Topic views
5,012Article views
1,712Article downloads